Addressing Bone Disease in Lysosomal storage diseases
Missed the live session? No worries!
11 February 2025
Online
Join Dr. Andreas Kindmark as he discusses the assessment of bone health and the management of bone disease in patients with Lysosomal Storage Diseases (LSDs).
This session covers:
- The critical role of early identification and accurate measurement of bone disease
- Techniques and methodologies for assessing bone health
- Insights into how bone involvement manifests in various lysosomal storage disorders
About Dr. Andreas Kindmark
Dr. Andreas Kindmark is an MD, Associate Professor, and Senior Consultant at Uppsala University Hospital, Sweden. He is a Certified Clinical Densitometrist, and coordinating Process Leader for the Uppsala University Hospital national highly specialized care (NHV) units for skeletal dysplasias and osteogenesis imperfecta. He is also a member of the Management and Monitoring working group for the International Working Group for Gaucher disease. Specialized in metabolic diseases, bone, and mineral metabolism, he brings invaluable expertise to this discussion.
Who should watch?
This webinar is interesting for:
- Endocrinologists
- Hematologists
- Radiologists
Part I: Bone Health Fundamentals & Diagnostic technologies
Gain a deeper understanding of how bone mass changes throughout life and why it matters to patients with LSDs. In this video, explore advanced techniques for assessing bone health, and learn the critical roles of different bone cells in maintaining skeletal integrity.
Part II: The impact of LSDs on Bone Health
How can early intervention prevent irreversible bone damage in patients with LSDs? Explore how LSDs, especially Gaucher disease, impact skeletal health. Learn how advanced imaging techniques can enhance diagnosis and guide better treatment strategies, ultimately improving the quality of life for patients.
